Keywords: ALG; alginate; Cm; capreomycin; CHI; chitosan; DPIs; dry powder inhalers; E; ethambutol; EC; ethyl cellulose; ECM; extracellular matrix; Eto; ethionamide; FPF; fine particle fraction; HA; hyaluronic acid; HIP/PCA; hydrophobic ion-pairing/precipitation wit
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Active pharmaceutical ingredients; Tuberculosis; Ethionamide; Solubility; X-ray diffraction; Vibrational spectroscopy;
Keywords: tuberculosis; ethionamide; porous particles; bioavailability; pharmacokinetics and pulmonary absorption; AUC; area under the curve; BAL; bronchoalveolar lavage; CL; apparent total body clearance; CV%; coefficient of variation; DPAG; dry powder aerosol gen
Keywords: Chitosan-alginate nanoparticles; Carrageenan stabilized nanoparticles; Nanoparticles; Ethionamide; Controlled release;
Keywords: Ethionamide (PubChem CID: 2761171); Isothiocyanatofluorescein (PubChem CID: 18730); β-Cyclodextrin (PubChem CID: 444041); Cyclodextrin; Polymers; Ethionamide; Tuberculosis; Delivery; Binding; Fluorescence;
Keywords: TB; tuberculosis; MTB; Mycobacterium tuberculosis; MDR-TB; multi-drug resistant tuberculosis; XDR-TB; extensively drug resistant tuberculosis; TDR-TB; totally drug resistant tuberculosis; INH; isoniazid; WHO; World Health Organization; RIF; rifampicin; PZ
Keywords: Chitin (PubChem CID: 6857375); Ethionamide (PubChem CID:2761171); Methacycline (PubChem CID: 54675785); Rifampicin (PubChem CID: 5381226); Chitin nanoparticles; Ethionamide; Methacycline; Molecular docking; Anti-bacterial; Drug loading;
Keywords: Solution thermodynamics; Ethionamide; Partition coefficient; HYBOT descriptors
Keywords: Ethionamide; Prothionamide; Thioamides; Children; Tuberculosis treatment; Pharmacokinetics; Safety;
Keywords: Pyrazinamide; Ethionamide; Square-wave voltammetry; Poly(l-Cys)/GCE; Simultaneous determination;
Keywords: Antituberculosis drugs; Carbothioamide compounds; Chemoinformatics; Docking simulation; Ethionamide; Prothionamide; Tyrosinase inhibitors;
Keywords: ZrO2/GCE sensor; Ethionamide; Voltammetry; Surfactant;
Keywords: bioequivalence; ethionamide; tuberculosis; Trecator;
Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance?
Keywords: Multidrug-resistant tuberculosis; Whole-genome sequencing; TB profiler; TGS-TB; PhyResSE; Mykrobe predictor; AMK; Amikacin; CAP; Capreomycin; CICLO; Cicloserine; DST; Drug Susceptibility Testing; EMB; Etambutol; ETH; Ethionamide; FLQ; Fluoroquinolones; IG
Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis
Keywords: Tuberculosis; Oxadiazolone; Lipolytic enzyme inhibitors; Activity-based probe (ABP); ABPP; activity-based protein profiling; CC50; compound concentration leading to 50% of cell cytotoxicity; CyC; Cyclipostins & Cyclophostin analogs; ETO; ethionamide; FM;
Preparation and biological evaluation of ethionamide-mesoporous silicon nanoparticles against Mycobacterium tuberculosis
Keywords: Ethionamide; Porous silicon nanoparticles; Mycobacterium tuberculosis; Strain H37Rv; MIC50;
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs
Keywords: Polymerized β-Cyclodextrin; Nanoparticles; Ethionamide; Booster; BDM43266; Tuberculosis; Combination therapy;
PLGA Ethionamide Nanoparticles for Pulmonary Delivery: Development and in vivo evaluation of dry powder inhaler
Keywords: Ethionamide; PLGA; Nanoparticles; Dry powder inhaler; In-vivo study;
Structural analysis of the interaction between spiroisoxazoline SMARt-420 and the Mycobacterium tuberculosis repressor EthR2
Keywords: Transcriptional repressor; TetR family; Ethionamide; Crystal structure; Ligand-binding interaction; Drug design;
Spectrophotometric determination of ethionamide in pharmaceuticals using Folin-Ciocalteu reagent and iron(III)-ferricyanide as chromogenic agents
Keywords: Ethionamide; Folin-Ciocalteu reagent; Iron(III); Ferricyanide; Spectrophotometry; Pharmaceuticals;
Pharmaceutical salts of ethionamide with GRAS counter ion donors to enhance the solubility
Keywords: API; active pharmaceutical ingredient; ETH; ethionamide; CNB; 2-chloro-4-nitrobenzoic acid; 2,6HBA; 2,6-dihydroxybenzoic acid; 2,3HBA; 2,3-dihydroxybenzoic acid; DNB; 2,4-dinitrobenzoic acid; SCXRD; single crystal x-ray diffraction; PXRD; powder X-ray dif
Suppression of NRF2–ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells
Keywords: NRF2; Chemotherapeutic resistance; Arsenic trioxide; Leukemia; Ethionamide; Isoniazid; Cytotoxicity
Multinuclear NMR analysis of the antitubercular drug ethionamide
Keywords: Chemical reactivity; Ethionamide; 15N NMR; 33S NMR; Thioamide; Tuberculosis;
Characterization of a new Baeyer-Villiger monooxygenase and conversion to a solely N-or S-oxidizing enzyme by a single R292 mutation
Keywords: BVMO; Flavoprotein; Drug metabolites; Stopped-flow; Ethionamide; Isothermal calorimetry
An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy
Keywords: AA; Ascorbic acid; AEM1; ARE expression modulator 1; AEG1; Astrocyte elevated gene-1; Akt; Protein kinase B; AMPK; AMP-activated protein kinase; APL; Acute promyelocytic leukemia; ARE; Antioxidant response element; ATO; Arsenic trioxide; Bach; BTB and CNC
Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960
Keywords: Pyrazinamide; Resistance; Tuberculosis; pncA; MGIT960; Drug susceptibility testing; H; isoniazid; R; rifampicin; E; ethambutol; PZA, Z; pyrazinamide; Eto; ethionamide; Am; amikacin; Cm; capreomycin; Lfx; levofloxacin; PZase; pyrazinamidase; POA; pyrazinoi
Combination comet/micronucleus assay validation performed by BioReliance under the JaCVAM initiative
Keywords: In vivo comet assay; JaCVAM validation study; 1,3-Dichloropropene; Ethionamide; Busulfan; In vivo micronucleus (MN) assay; Combination comet/MN assay;
The Mycobacterium tuberculosis transcriptional repressor EthR is negatively regulated by Serine/Threonine phosphorylation
Keywords: Ser/Thr protein kinases; EthR; Mycobacterium; Phosphorylation; Ethionamide;
Cloning and expression of a Baeyer-Villiger monooxygenase oxidizing linear aliphatic ketones from Dietzia sp. D5
Keywords: BVMO; Baeyer-Villiger monooxygenase; BVMO3; Dietzia sp. D5 BVMO; EthA; ethionamide monooxygenase; MO0565c and MO3083; Mycobacterium tuberculosis BVMOs; MO13 and MO16; Rhodococcus jostii BVMOs; BVMO Pp; Pseudomonas putida BVMO; BVMO Ar; Acinetobacter rad
Optimization of the conventional minimum inhibitory concentration method for drug susceptibility testing of ethionamide
Keywords: Ethionamide; Drug susceptibility testing; MIC; Diluted inoculum; Mycobacterium tuberculosis; PST
The effect of anti-tubercular drug, ethionamide on the secondary structure of serum albumins: A biophysical study
Keywords: Serum albumin; Ethionamide; Binding mechanism; Energy transfer; Site probes; Secondary structure
New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles
Keywords: Caco-2; Drug release; Ethionamide; HepG2; Porous silicon; Metabolism
Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases
Keywords: ETA, ethionamide; FMO, flavin-containing monooxygenase; GSH, glutathione; INH, isoniazid; ISO, isoxyl; PTA, prothionamide; TAZ, thiacetazoneAntituberculosis drugs; Drug metabolism; Flavin monooxygenases; Thiacetazone; Ethionamide; Isoxyl
Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing
Keywords: Tuberculosis; Drug-resistant; Rifampin; Isoniazid; Ethionamide; Rapid detection;
Cytotoxicity decreasing effect and antimycobacterial activity of chitosan conjugated with antituberculotic drugs
Keywords: Chitosan; Isoniazid; Pyrazinamide; Ethionamide; In vitro antimycobacterial activity; Cytotoxicity
Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes
Keywords: Ethionamide; Tuberculosis; Flavin-containing monooxygenase
Insights into mechanisms of induction and ligands recognition in the transcriptional repressor EthR from Mycobacterium tuberculosis
Keywords: Ethionamide; Helix-turn-helix; Mycobacterium tuberculosis; TetR family; X-ray crystallography; Drug design